Drug Safety System Is Under Way

NOVEMBER 01, 2006

The FDA and Massachusetts Institute of Technology are developing an automated system to identify unanticipated problems with prescription drugs and medical devices. The system would search federal and private health care databases for atypical and emerging patterns that could indicate potential safety concerns.

The agency's current system relies mainly on the manual assessment of reports voluntarily submitted to the FDA. The reports sometimes come months or years after an event has occurred. A more technologically advanced system capable of watching multiple databases would be better at detecting patterns suggestive of emerging problems, noted Scott Gottlieb, MD, the FDA's deputy commissioner for scientific and medical affairs. He added that the system would be built on methods created to identify infectious disease outbreaks, detect bioterrorism attacks, and model the spread of the avian flu.


Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 


Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference

Personalize the information you receive by selecting targeted content and special offers.